imo, DNDN's Provenge will not get approval, now or ever.
imo, DNDN should be shorted on all rises. Provenge, imo, will simply not be approved, now or ever.
The FDA does not believe that the body can heal itself. Approving drugs like Provenge will set the stage for the eventual approval of natural therapeutics (which focuses entirely on stimulating the body to heal itself). Natural therapeutics are cheap and are not patentable; therefore, no multibillion dollar profits for big pharma.
No Provenge. No way, no how.
The FDA does not believe that the body can heal itself. Approving drugs like Provenge will set the stage for the eventual approval of natural therapeutics (which focuses entirely on stimulating the body to heal itself). Natural therapeutics are cheap and are not patentable; therefore, no multibillion dollar profits for big pharma.
No Provenge. No way, no how.
posted by beanie11111 | 12:57 AM
4 Comments:
Chinese markets taking quite the beating...atleast the rest of asia is stable enough
Good idea! Short DNDN into oblivion!!!
you have to be insane to short DNDN. look at the calls for this month, and you know you'll get burned big time. to give you an example, DNDN climbed $5 within 12 minutes of trading on rehashed news last week. why? because 50% of the stock is short now, and there are no new shares to short. given the short interest, even the whiff of any good news (ROW partnership etc) will send it to the $15s within the blink of an eye.
do yourself a favor. and don't short DNDN unless you wanna end up a bag holder. even the $75m convertible news today can't hold it down, it's clawing its way back up. and there's a good reason for it. good luck.
Any big rises (only) in DNDN need to be shorted with put options.
Post a Comment
<< Home